Tamoxifen-induced venous thromboembolism in a young male

被引:0
作者
Niazy, Mohammed N. [2 ]
Neyyarapally, Thomas I. [2 ]
Chattopadhyay, Arijit [1 ]
Ud-din, Shuja [2 ]
Elfar, El Sayed [3 ]
机构
[1] Al Sabah Hosp, Sheikhan Al Farsi Ctr, Dept Endocrinol, Minist Hlth, Safat 13023, Kuwait
[2] Al Sabah Hosp, Minist Hlth, Dept Med, Safat, Kuwait
[3] Al Sabah Hosp, Minist Hlth, Dept Radiol, Safat, Kuwait
关键词
tamoxifen; venous thromboembolism; anticoagulant;
D O I
10.1097/TEN.0b013e318171b79c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 25-year-old man was being treated with tamoxifen for oligozoospermia. He was admitted with progressive shortness of breath, hemoptysis, and left-sided pleuritic chest pain for 5 days. Pulmonary embolism was suspected based on presenting symptoms, electrocardiogram, chest x-ray examination, ventilation-perfusion (V/Q) scan, and confirmed by computed tomography (CT) pulmonary angiography. CT pulmonary angiography showed a large pulmonary embolism, but additional investigations failed to reveal a primary source of embolism eg, deep vein thrombosis or right-. sided cardiac thrombus. The patient was treated with IV heparin. The clot resolved completely, demonstrated by follow up CT angiography, and he was discharged on oral anticoagulation. Antithrombin III level was significantly reduced (31% activity). The cause of venous thromboembolism may have been thrombophilia induced by tamoxifen.
引用
收藏
页码:111 / 113
页数:3
相关论文
共 16 条
[1]   The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia [J].
Adamopoulos, DA ;
Nicopoulou, S ;
Kapolla, N ;
Karamertzanis, M ;
Andreou, E .
FERTILITY AND STERILITY, 1997, 67 (04) :756-762
[2]   Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia [J].
Adamopoulos, DA ;
Pappa, A ;
Billa, E ;
Nicopoulou, S ;
Koukkou, E ;
Michopoulos, J .
FERTILITY AND STERILITY, 2003, 80 (04) :914-920
[3]   Long-term effect of 17β-estradiol and thrombin on tissue factor pathway inhibitor release from HUVEC [J].
Bilsel, AS ;
Onaran, N ;
Moini, H ;
Emerk, K .
THROMBOSIS RESEARCH, 2000, 99 (02) :173-178
[4]   Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor [J].
Bladbjerg, EM ;
Skouby, SO ;
Andersen, LF ;
Jespersen, J .
HUMAN REPRODUCTION, 2002, 17 (12) :3235-3241
[5]   Male idiopathic oligoasthenoteratozoospermia [J].
Cavallini, G .
ASIAN JOURNAL OF ANDROLOGY, 2006, 8 (02) :143-157
[6]  
COMHAIRE F, 1976, INT J FERTIL, V21, P232
[7]   Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial [J].
Cushman, M ;
Costantino, JP ;
Bovill, EG ;
Wickerham, DL ;
Buckley, L ;
Roberts, JD ;
Krag, DN .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) :109-116
[8]   Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial [J].
Decensi, A ;
Maisonneuve, P ;
Rotmensz, N ;
Bettega, D ;
Costa, A ;
Sacchini, V ;
Salvioni, A ;
Travaglini, R ;
Oliviero, P ;
D'Aiuto, G ;
Gulisano, M ;
Gucciardo, G ;
del Turco, MR ;
Pizzichetta, MA ;
Conforti, S ;
Bonanni, B ;
Boyle, P ;
Veronesi, U .
CIRCULATION, 2005, 111 (05) :650-656
[9]   Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state? [J].
Erman, M ;
Abali, H ;
Oran, B ;
Haznedaroglu, IC ;
Canpinar, H ;
Kirazli, S ;
Celik, I .
ANNALS OF ONCOLOGY, 2004, 15 (11) :1622-1626
[10]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388